Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Fauci Warns of 'Suffering and Death' if U.S. Reopens Too Soon
Dr. Anthony Fauci, the nation’s top infectious disease expert, is warning Congress and the nation of what he calls "really serious” consequences of suffering, death and deeper economic damage if state and local officials lift stay-at-home orders too quickly.
What The Pronunciations Of Brand Names Really Mean
Marketers use a linguistic science called ‘Sound Symbolism’ to aid in naming brands and products. The science focuses on the sounds of words and how they can affect how people perceive a word. Join Cheddar as we examine just how brand names come to be formed and if a brand by any other name is just as lucrative.
U.S. Shelves Detailed Guide to Reopening Country: AP
The Trump administration has shelved a set of detailed documents created by the nation’s top disease investigators meant to give step-by-step advice to local leaders deciding when and how to reopen public places during the still-raging pandemic.
Load More